Target intelligence / Profile preview

Invigorate Blood

01

Overview

"Invigorate Blood" (known in Traditional Chinese Medicine as Huoxue) is not a specific molecular target, receptor, or enzyme, but rather a therapeutic principle and pharmacological category used to describe substances that improve blood circulation and resolve blood stasis. In modern pharmacology, this category refers to agents that possess anti-thrombotic, anti-coagulant, and vasoactive properties. These agents often act on multiple targets simultaneously, such as platelets, endothelial cells, and the coagulation cascade, rather than a single protein. Common bioactive compounds associated with this category include salvianolic acids and tanshinones, which are frequently studied for their roles in treating cardiovascular and cerebrovascular diseases. Because it is a broad therapeutic action rather than a specific biological molecule, it cannot be classified under standard molecular target nomenclatures.

Other names
Promoting blood circulation and removing blood stasisHuoxue HuayuBlood-activating and stasis-dispellingImproving blood rheology
02

Mechanism of action

Drugs categorized as 'Invigorate Blood' typically function by inhibiting platelet aggregation, reducing blood viscosity, promoting fibrinolysis, and inducing vasodilation through various signaling pathways such as the inhibition of thromboxane A2 or the enhancement of nitric oxide production.

03

Biological functions

Regulation of blood coagulationVasodilationFibrinolysisInhibition of platelet aggregationMicrocirculation improvement
04

Disease associations

Cardiovascular diseaseIschemic strokeThrombosisChronic inflammationPeripheral artery disease
05

Safety considerations

Increased risk of hemorrhage or excessive bleedingDrug-drug interactions with clinical anticoagulants (e.g., Warfarin, Aspirin)Potential for herb-drug interactions in perioperative settings
06

Interacting drugs

Salvia miltiorrhiza (Dan Shen) extracts

4 more in the full profile.

07

Biomarkers

Prothrombin time (PT)Activated partial thromboplastin time (aPTT)D-dimer levelsPlatelet aggregation rateWhole blood viscosity

Beyond the preview

Go deeper on Invigorate Blood.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invigorate Blood.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call